Novo Nordisk A/S (NVO)
NYSE: NVO · Real-Time Price · USD
37.45
-0.17 (-0.45%)
At close: Feb 27, 2026, 4:00 PM EST
37.49
+0.04 (0.10%)
After-hours: Feb 27, 2026, 7:59 PM EST
Novo Nordisk Operating Income by Segment
History
| Date | Diabetes and Obesity Care | Rare Disease |
|---|---|---|
| Sep 30, 2025 | 20.73B | 191.62M |
| Jun 30, 2025 | 22.19B | 331.83M |
| Mar 31, 2025 | 21.25B | 84.53M |
| Dec 31, 2024 | 20.14B | 97.78M |
| Sep 30, 2024 | 18.56B | 104.25M |
| Jun 30, 2024 | 17.50B | 79.49M |
| Mar 31, 2024 | 16.82B | 431.35M |
| Dec 31, 2023 | 15.71B | 465.41M |
| Sep 30, 2023 | 14.29B | 365.74M |
| Jun 30, 2023 | 12.93B | 654.99M |
| Mar 31, 2023 | 11.86B | 865.85M |
| Dec 31, 2022 | 10.63B | 1.17B |
| Sep 30, 2022 | 9.82B | 1.43B |
| Jun 30, 2022 | 9.02B | 1.46B |
| Mar 31, 2022 | 8.43B | 1.48B |
| Dec 31, 2021 | 7.81B | 1.44B |
| Sep 30, 2021 | 7.38B | 1.48B |
| Jun 30, 2021 | 6.86B | 1.62B |
| Mar 31, 2021 | 6.74B | 1.58B |
| Dec 31, 2020 | 6.90B | 1.64B |
Source: Business metrics provided by Main Street Data and sourced from official company press releases and documents.